Magdalena Biosciences To Present At BIO Investor Forum Oct 16
10 Oct 2024 //
ACCESSWIRE
PharmAla and Filament Announce Release of Second Batch of GMP MDMA Capsules
15 Nov 2023 //
GLOBENEWSWIRE
Filament Health announces FDA approval of Phase II trial studying psilocybin
16 Mar 2023 //
NEWSWIRE
Psyence and Filament Announce Licensing Agreement of Psilocybin Capsule
15 Dec 2022 //
GLOBENEWSWIRE
FILAMENT HEALTH AND ATMA JOURNEY CENTERS ANNOUNCE 14 SUBJECTS DOSED
01 Sep 2022 //
NEWSWIRE
Filament Health Begins Dosing in Groundbreaking FDA-Approved Psilocin Trial
07 Jul 2022 //
BUSINESSWIRE
Psyence and Filament Health Enter Into Exclusive Licensing Agreement
19 Apr 2022 //
GLOBENEWSWIRE